Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.
Exposure Risk Assessment Challenges:
Occupational Hygiene in the Pharmaceutical
and Chemical Industries
AIHA 2013
Asia Pac...
Agenda: Two Part Presentation
Part 1: Maharshi Mehta
 Growing need for sustainable Industrial hygiene
and process safety ...
Part-2 : Samson - Agenda
1. Background /Introduction
A. Why is this important ?
B. HSE Trends in Asian countries
C. IH in ...
Introduction
 Pharmaceutical manufacturing is growing 8% to
12% per year in emerging economies
 India is the world’s lar...
Infrastructure
 Over 450
colleges/departments offering
degree and other education
programs in pharmaceutical
science
 Mo...
Introduction-Pharmaceutical and
Chemical Industries
 Active Pharmaceutical Ingredient (API)
Manufacturing similar to typi...
API/Chemical Manufacturing –Process Safety
– The highest priority
 Low flash points solvent. Most commonly used:
– Toluen...
Example of Process Safety Incident
A massive explosion and fire
gutted a pharmaceutical supply
plant, killing at least thr...
Process Safety - Most
common recommendations
 Process safety risk is manageable
 Awareness and Risk Assessment (HAZOP)
...
Industrial Hygiene
Hazard Anticipation - Hazards likely to be present?
Hazard Recognition - What are health hazards?
Risk ...
Hazards – Exposures – Controls - and
Risk: example…Low Risk Compression
Activity
Health Hazard: API
Enclosed compression
m...
Industrial Hygiene - Methodology
(Compression)
 Health Hazard Identification
– Obtain hazard data for API from MSDS and l...
Hierarchy of Controls
 Elimination – Avoid Compression?
 Substitution – Use of low potency
compound?
 Process Changes –...
API Chemical Plants: Health
Hazards - Solvents
 Toluene and DMF
– Potential reproductive hazards
 Acetonitrile
– CN form...
API/Chemical Plants: Solvent
Exposure Potential to Exceed
OEL
 Solid liquid separation – Centrifuge - Manual
digging
 Sh...
API/Chemical Plants: Solvent
Exposure Controls
 Agitated Nutche
Filter/Filter Dryer in place
of Centrifuge
 Tanker QC sa...
Acute Pharmacological Effects
Pharma compound Exposure Incident: An operator
working on the manufacture of a product conta...
Hormones
Endocrine Gland Hormone Main function(s)
Pancreas Insulin Regulates blood sugar levels.
Thyroid
Triiodothyronine ...
Steroids – Health Effects
 Male Employees:
– Gynecomastia (excessive development of the mammary
glands), decreased libido...
Antibiotics - Health Effects
 Allergic reactions:
– Itching and redness of eyes, runny nose, skin rashes,
asthma, anaphyl...
 Acute effects: severe soft-tissue damage, fetotoxicity,
headaches, lightheadedness, dizziness, nausea and allergic
react...
OELs
 Occupational Exposure Limits (OELs)
 Airborne concentration limit of a substance to which it is believed that
a wo...
Adjusted Occupational Exposure Limits (AOEL)*
Activity Duration Activity Multiplier (AM)
Up to 10 min 5
> 10 to 30 min 3
F...
Occupational Exposure Bands (OEBs) – Categorization
OEB 2
1000 - 100 ug/m3
OEB 3
100 - 10 ug/m3
OEB 1
5000- 1000 ug/m3
OEB...
Risk Assessment Model
 Most model considers
– Potency
– Frequency duration of exposure
– Air-borne Potential
– Exposure C...
High Potent Compound in
Chemical Industries
 Beryllium - OEL 2 ug/m3
 Hex chrome – OEL 5 ug/m3
 Ni Carbonyl – OEL 50 pp...
Rank Frequency Duration Health Hazard
Daily Weekly monthly Yearly Chemicals API
1
Minimal
(under 30
minutes)
Any / Minimal...
Rank
Airborne Potential
Engineering
Control
Skin Exposure
Skin Hazard
Exposure
Potential
1 Low
Total enclosure
validated b...
Final Risk Ranking Criteria
©International Safety Systems, Inc.
www.issehs.com
Description
Final Risk
Ranking
1-100
Low Ri...
Quantitative Exposure
Monitoring
Sampling pump
Sampling media
Sampling media
Calibrator
Important Considerations
 What to sample?
– Contaminants with higher degree of toxicity with potential
for exposure ident...
Important Considerations
 How many samples to be collected?
– 6 (minimum) for each contaminant in SEG
– Additional sample...
Challenges in API Exposure
Monitoring
 OELs are not available for large number of APIs and
intermediates
 Validated meth...
Addressing Challenges API
Exposure Monitoring
 Use validated methods and accredited lab with API
analysis experience espe...
Surrogate Monitoring
Good Practices Guidelines - ISPE
 International Society for Pharmaceutical Engineering (ISPE)
 Stan...
Example of Laminar
Flow
Booth Surrogate
Monitoring at LFB
API/Chemical Plants: Exposure Controls:
Reactor Charging
 Potential for exposure during:
– Manual charging of solids
– Ha...
API/Chemical Plants: Exposure Controls: Tanker
Unloading
Nitrogen – pushing
residual chemical
Secured connections with
arr...
API/Chemical Plants: Exposure Controls: Tanker
Unloading Barrel Transfer of Chemicals
Potential for exposure during transf...
Dispensing and Weighing of Solids - Small
Volume
Not Effective: LFB are nt effective in
reducing exposure below about 50 u...
Solid
Discharging
Fully Contained Discharge Through Weigh Isolator
Ventilated Balance Safety Enclosure
(VBSE)® – For High Potent
Compounds in laboratory
 Face velocity
– Not too high
– Not...
Efficient LEV design
Principles of General Ventilation System
 Maintain always negative air pressure in the
contamination generating room with...
Efficient Local Exhaust Ventilation (LEV)
 Inefficient ventilation system design is one of the most
common walkthrough fi...
Hood
Provide a flange or hood at the air inlet. 25% more energy is required to
capture contaminates from the front, when a...
Hood
Tapered hood are more efficient than right angle hoods
Locate hood so that contaminants do not pass through the
breat...
Duct
Straight duct is more efficient than a duct with many
bends and elbows. Smaller duct length and smoother duct
surface...
Application of LEV
Solid charging
Empty bags are placed in this large bag
Solid filling in drums
Barrel decanting
Glove bo...
Ventilation measurements
 Velocity measurement on
the face of the hood is best
indicator of efficiency
 Depending on the...
Range of Capture Velocities
Condition
of
Dispersion
Examples Capture Velocity
(f/min)
Capture
Velocity
(m/sec)
Released wi...
Range of Duct Velocities
Material Example Duct Velocity
(f/min)
Duct velocity
(m/sec)
Vapors, gases All vapors and gases 1...
Measuring Ventilation System
Performance
Manometer/Magneh
elic gauge that
continuously
measures pressure
drop across filte...
HVAC System and Dust
Collectors
 Directional flow in Room: Clean air flows top-down and
contaminated air flows bottom-sid...
Zoning for High Potent
Compound Handling
 Red
– Potentially contaminated area
– Not used for gowning
 Yellow
– Less or n...
Importance of Swab Sampling
to determine degree of surface
contamination
 Determines degree of surface
contamination
 Us...
Gowning –Degowning for High
Potent Compounds
 Two pairs of disposable
– Gloves
– Gowns
– Shoe Cover
 Disposal of outer p...
Challenges in Respiratory
Protection
 Variable Assigned Protection Factor for
Powered Air Purifying Respirators
– 50 to 1...
Challenges
 Limited Resources – IH professionals
 QA in exposure assessment data
 Financial constrains
– Price Controls...
Approaches: Corporate and
Regional EHS
 Commendable efforts
 Audits
 Regional training programs and meetings
 Strong c...
Approaches
 Education Programs in Industrial Hygiene
– University Level
– Pharma specific training modules
 Managing cos...
Approaches
 Empowering region and manufacturing sites in
EHS
 Training
– At the foundation of sustainable EHS program
– ...
Approaches – Supply Chain
 Corporate requirement for supplier to demonstrate
exposure is below OEL through surrogate moni...
Conclusions
 Potential process safety and chemical exposure risks are
high in pharmaceutical and chemical industries. The...
Prochain SlideShare
Chargement dans…5
×

Exposure Risk Assessment Challanges

Exposure Risk Assessment Challenges : Occupational Hygiene in the Pharmaceutical and Chemical Industries, AIHA 2013, Asia Pacific OH Conference, Singapore

  • Soyez le premier à commenter

Exposure Risk Assessment Challanges

  1. 1. Exposure Risk Assessment Challenges: Occupational Hygiene in the Pharmaceutical and Chemical Industries AIHA 2013 Asia Pacific OH Conference, Singapore Maharshi Mehta, CSP, CIH President International Safety Systems, Inc., Washingtonville New York, USA www.issehs.com Samson Ponselvan Head, Corporate EHS Shasun Pharmaceuticals Limited, Chennai, India
  2. 2. Agenda: Two Part Presentation Part 1: Maharshi Mehta  Growing need for sustainable Industrial hygiene and process safety in Emerging Economies  Introduction to potential health and process safety risk  Risk Assessment and Risk Controls  Challenges Encountered  Approaches adopted  Lessons Learned ©International Safety Systems, Inc. www.issehs.com
  3. 3. Part-2 : Samson - Agenda 1. Background /Introduction A. Why is this important ? B. HSE Trends in Asian countries C. IH in Pharma and Chemical industries 2. Challenges in managing potential health risks and solutions 3. Hierarchy of controls - At Source / At Path / At Work 4. IH Management System Models 5. Integration of IH and handling of potent APIs 6. Conclusion Slide 3
  4. 4. Introduction  Pharmaceutical manufacturing is growing 8% to 12% per year in emerging economies  India is the world’s largest producer of bulk drugs  Supply chain, third party manufacturing are increasing rapidly  Outsourcing expected to exceed $53B  More than 100 FDA-approved pharmaceutical facilities are in India- the largest number in any country outside the U.S 4
  5. 5. Infrastructure  Over 450 colleges/departments offering degree and other education programs in pharmaceutical science  More than 50,000 students graduates/year  Manufacturing equipment, containment technologies  R&D centers , laboratories  Two colleges offering Master in Industrial Hygiene Program  150 Industrial Hygienists for all companies in India total  5 CIHs  Safety professionals or occupational physicians practicing IH  No Accredited Lab for API/Surrogate 5 Pharma Manufacturing EHS
  6. 6. Introduction-Pharmaceutical and Chemical Industries  Active Pharmaceutical Ingredient (API) Manufacturing similar to typical chemical industries – Bulk drug is manufactured – Potential process safety risk and chemical exposure risk is high – Large volume potential solid exposure risk is high after solid liquid separation  Formulation or Dosage Form – Solids and liquid pharmaceuticals are made – Potential solid API exposure risk is high ©International Safety Systems, Inc. www.issehs.com
  7. 7. API/Chemical Manufacturing –Process Safety – The highest priority  Low flash points solvent. Most commonly used: – Toluene, Methanol, Dimethyl Formamide, Acetonitrile  Unit operations – Tanker unloading and tank farm, barrel transfer – Reactor vessel charging and cleaning – Solid liquid separation, distillation  Most common Contributory factors – Open handling of solvents – Validation of inerting – Non-conductive container handling – Effectiveness of grounding and bonding – “Explosion Proof” lighting©International Safety Systems, Inc. www.issehs.com
  8. 8. Example of Process Safety Incident A massive explosion and fire gutted a pharmaceutical supply plant, killing at least three people and injuring more than two dozen others -- about 12 of them critically. A volatile mix of air and suspended dust caused the explosion The explosion was so powerful it blew doors open on houses more than a mile away and sent debris flying, with some pieces landing more than two miles away Authorities recommended residents within a mile radius around the plant to evacuate
  9. 9. Process Safety - Most common recommendations  Process safety risk is manageable  Awareness and Risk Assessment (HAZOP)  Storage tank integrity, flame arrestor breather valves, dyking  Validation of inerting-flow rate, volume, O2<4%. Inerting of not just process vessels – Centrifuge  Static electricity controls – Painted surfaces – Continuity, resistance and earthing  Conductive containers  Specifics on intrinsically safe lighting ©International Safety Systems, Inc. www.issehs.com
  10. 10. Industrial Hygiene Hazard Anticipation - Hazards likely to be present? Hazard Recognition - What are health hazards? Risk Evaluation - Exposed to health hazard? How much? Risk Control - How can exposure be reduced? And potential for occupational illnesses, material loss are reduced and the company liability minimized So that…Health risk is minimized
  11. 11. Hazards – Exposures – Controls - and Risk: example…Low Risk Compression Activity Health Hazard: API Enclosed compression machine Potential for exposure from fugitive emission Reduced risk due to effective use of airline respirator
  12. 12. Industrial Hygiene - Methodology (Compression)  Health Hazard Identification – Obtain hazard data for API from MSDS and label  Exposure/Risk Assessment – How frequently and how long compression machine is running? – How frequently compression machine is cleaned? – Are exposure controls effective in reducing exposure? – Are recommended RPE/PPEs used? – Is exposure monitoring conducted? – Is the exposure below OEG?
  13. 13. Hierarchy of Controls  Elimination – Avoid Compression?  Substitution – Use of low potency compound?  Process Changes – Vacuum transfer blend in compression hopper? – Not feasible due to business constraints e.g., product validation and registration process  Engineering Controls – Complete enclosure of compression machine and tablet container?  Administrative Controls – Reducing or restricting exposure duration?  Personal Protective Equipment and Respiratory Protective Equipment – Eye Protection, cleaning disinfecting respirator, storing respirator in a zip lock plastic bag?
  14. 14. API Chemical Plants: Health Hazards - Solvents  Toluene and DMF – Potential reproductive hazards  Acetonitrile – CN formation  Tetrahydrofuran (also peroxide forming agent)  Isopropanol  Small Volume Highly Toxic compounds – Aniline – Iodine ©International Safety Systems, Inc. www.issehs.com
  15. 15. API/Chemical Plants: Solvent Exposure Potential to Exceed OEL  Solid liquid separation – Centrifuge - Manual digging  Short term exposure – Tanker/barrel QC Sample taking, tanker hose disconnecting, residual tanker solvent collecting  Reactor, vessel cleaning  Distillation residue collection ©International Safety Systems, Inc. www.issehs.com
  16. 16. API/Chemical Plants: Solvent Exposure Controls  Agitated Nutche Filter/Filter Dryer in place of Centrifuge  Tanker QC sample from bottom nozzle and not by opening dome  Nitrogen for pushing solvents before opening hose after tanker unloading  Local Exhaust Ventilation ©International Safety Systems, Inc. www.issehs.com
  17. 17. Acute Pharmacological Effects Pharma compound Exposure Incident: An operator working on the manufacture of a product containing Barbiturates was admitted to hospital in hypoglycaemic coma and the report of a study by the Pharma company found that operators absorbed through skin significant levels of Barbiturates. Health effects described in this and subsequent slides potentially could occur from overexposure when effective exposure controls are not in place. ©International Safety Systems, Inc. www.issehs.com
  18. 18. Hormones Endocrine Gland Hormone Main function(s) Pancreas Insulin Regulates blood sugar levels. Thyroid Triiodothyronine and thyroxine Development of the brain and reproductive tract, and regulation of metabolism Adrenal Cortisol Immune suppression and stress response Ovary Estrogens (estradiol, estrone, estriol) Growth promotion, maintain elasticity of connective tissues, preserve bone mass and, vascular compliance, Testosterone Precursor for oestrogen and acts on libido. Testis Testosterone Growth of male secondary sexual characteristics, sperm production and libido Dihydrotestosterone Some male secondary sexual characteristics. Placenta Progesterone Maintenance of pregnancy Overexposure to hormone during manufacturing, development and testing may result in elevated levels of hormone in the body and affect the normal functions of the related endocrine gland. ©International Safety Systems, Inc. www.issehs.com
  19. 19. Steroids – Health Effects  Male Employees: – Gynecomastia (excessive development of the mammary glands), decreased libido, reduced testicular size, increased pigmentation of the nipple area, nipple sensitivity, dysspermia (the occurrence of pain during ejaculation), weight loss, and headaches  Female Employees: – Menstrual disorders (such as increased flow or intermenstrual spotting), nausea, headaches, breast pain, leukorrhea (vaginal discharge), and swollen ankles  Adverse effect on skin such as acne and erythema ©International Safety Systems, Inc. www.issehs.com
  20. 20. Antibiotics - Health Effects  Allergic reactions: – Itching and redness of eyes, runny nose, skin rashes, asthma, anaphylaxis  Vitamin deficiency: – Workers with repeated exposure to antibiotics experience change in number and type of bacteria which are normally present in intestines which break down and absorb vitamins in intestines  Fungal infections: – Daily exposure to antibiotic dust can lead to fungal infections of the skin and nails. – Women workers may develop vaginal yeast infections following exposure to antibiotics ©International Safety Systems, Inc. www.issehs.com
  21. 21.  Acute effects: severe soft-tissue damage, fetotoxicity, headaches, lightheadedness, dizziness, nausea and allergic reactions  Effect on growth and reproduction of the normal cells as Cytotoxic drugs may not distinguish between normal and cancerous cells  Other secondary malignancies, such as bladder cancer and lymphoma  Chromosomal damage (e.g., Chlorambucil)  Testicular and ovarian dysfunction, including sterility  Biological effects (even at very low levels of absorption) Antineoplastic - Health Effects ©International Safety Systems, Inc. www.issehs.com
  22. 22. OELs  Occupational Exposure Limits (OELs)  Airborne concentration limit of a substance to which it is believed that a worker may be exposed, without adverse health effects, expressed as an average concentration.  The time weighted average concentration for 8 hr work-day, 40 hour work-week , to which nearly all workers may be repeatedly exposed, day after day, without adverse effect.  An OEL is substance-specific and is a level at which workplace exposure is expected to be without detectable pharmacological or toxicological effect in occupational circumstances.  Industrial Hygienists conduct personal exposure monitoring to assess employees’ exposure relative to these levels. Exposure limits are not a fine line between safe and dangerous concentrations
  23. 23. Adjusted Occupational Exposure Limits (AOEL)* Activity Duration Activity Multiplier (AM) Up to 10 min 5 > 10 to 30 min 3 From > 30 min up to 1 hour 2.5 From > 1 hour up to 2 hours 2 From > 2 hours up to 4 hours 1.5 From > 4 hours up to 8 hours 1 *AOEL = AM X OEL-TWA (basis ACGIH Excursion Limits)©International Safety Systems, Inc. www.issehs.com
  24. 24. Occupational Exposure Bands (OEBs) – Categorization OEB 2 1000 - 100 ug/m3 OEB 3 100 - 10 ug/m3 OEB 1 5000- 1000 ug/m3 OEB 4 10 - 1 ug/m3 1000 10 100 ≤1 OEB 5 ≤1 ug/m3 Not harmful, not irritating, low pharmacological activity e.g. predicted therapeutic dose >100mg/day, Examples – many excipients Harmful, may be irritant, Moderate pharmacological activity, predicted therapeutic dose >10 - 100mg/day, Examples – Loratadine 5000 Moderate toxic and /or high pharmacological activity, predicted therapeutic dose >1–10mg/day, Respiratory sensitizers and potent dermal sensitizers, Severe irritants and corrosives, also default category, Examples – many penicillin & cephalosporin antibiotics Toxic Serious irreversible effects, Carcinogens, Mutagens, Reproductive and Developmental Toxins, Potent respiratory sensitisers, predicted therapeutic dose 1mg/day, Examples –Corticosteroids, some oncology drugs Extremely toxic and or extremely high pharmacological activity predicted therapeutic dose 1mg/day, Serious irreversible effects, Potent Carcinogens, Mutagens, Reproductive and Developmental Toxins, Examples - potent hormones or hormone effectors, select anti-cancer drugs IncreasingToxicityand/orPotency ©International Safety Systems, Inc. www.issehs.com
  25. 25. Risk Assessment Model  Most model considers – Potency – Frequency duration of exposure – Air-borne Potential – Exposure Controls  Formulation – Small volume, less frequency/duration high potent compounds considerations  Potential skin and ingestion risks are also critical ©International Safety Systems, Inc. www.issehs.com Risk Ranking Criteria are summarized in next 3 slides
  26. 26. High Potent Compound in Chemical Industries  Beryllium - OEL 2 ug/m3  Hex chrome – OEL 5 ug/m3  Ni Carbonyl – OEL 50 ppb  Chloromethyl isothiazolone – Kethon – very low OEL used as biocide  Bis chloromethyl ether OEL 1 ppb ©International Safety Systems, Inc. www.issehs.com
  27. 27. Rank Frequency Duration Health Hazard Daily Weekly monthly Yearly Chemicals API 1 Minimal (under 30 minutes) Any / Minimal (under 5 hours) Any / Minimal (under 20 hours) Any / Minimal (under 250 hours) OEL in range 3.1 to 10 mg/m3 or > 1000 ppm OEB1, OEL >1000 µg/m3 2 About 30 min to < 2 hour 5 to 15 hours per week 20 to 60 hours per month 250 to 500 hours per year OEL in range 0.51 to 3 mg/m3 or 101 to 1000 ppm OEB 2, OEL 100 µg/m3 - 1000 µg/m3 3 About ½ Shift (2 to 4 hours) 15 to 25 hours per week 60 to 80 hours per month Use More Frequent Basis OEL in range 0.01 to 0.5 mg/m3 or 10 to 100 ppm OEB 3, OEL 100 µg/m3 - 1000 µg/m3 4 About ¾ Shift (4 to 7 hours) 25 to 30 hours per week Use More Frequent Basis Use More Frequent Basis OEL < 0.01 mg/m3 or < 10 ppm OEB 3, OEL 10 µg/m3 - 100 µg/m3 5 (over 7 hours) Use More Frequent Basis Use More Frequent Basis Use More Frequent Basis OEB 4, OEL 1 µg/m3 - 10 µg/m3 6 OEB 4, OEL 0.01 µg/m3 - 1 µg/m3 7 OEB 5, OEL < 0.01 µg/m3
  28. 28. Rank Airborne Potential Engineering Control Skin Exposure Skin Hazard Exposure Potential 1 Low Total enclosure validated by IH monitoring No skin hazard, temporary effects 2 Medium Total enclosure NOT validated 3 High 4 Moderate (LEV) validated Probable skin irritants, materials may cause dermatitis. Short term skin exposure 5 6 Moderate not Validated 7 Will cause skin irritation, sensitizers, corrosives (acids, caustics, nickel). Repeated-long Skin exposure 8 Non-fixed controls movable LEV 9 10 No controls Materials toxic to skin (ACGIH) Skin Skin exposure certain
  29. 29. Final Risk Ranking Criteria ©International Safety Systems, Inc. www.issehs.com Description Final Risk Ranking 1-100 Low Risk – process is well controlled and personal exposures are obviously unlikely to become significant – no further action required other than periodic review 1 100- 200 Medium Risk - Further evaluation required by monitoring. 2 200- 300 Potenial High risk - implement exposure controls, conduct exposure monitoring, control employee exposure using respiratory protection until engineering controls are implemented 3 > 300 Very High Risk -Implement exposure controls immediately 4
  30. 30. Quantitative Exposure Monitoring Sampling pump Sampling media Sampling media Calibrator
  31. 31. Important Considerations  What to sample? – Contaminants with higher degree of toxicity with potential for exposure identified during qualitative exposure assessment  Whom to sample? – Personnel potentially exposed to identified contaminants  Are all personnel required to be sampled? – No, sample few from those having similar exposures known as Similar Exposure Group (SEG) (e.g., charging personnel, Dispensing personnel)
  32. 32. Important Considerations  How many samples to be collected? – 6 (minimum) for each contaminant in SEG – Additional samples need to be collected for high potent compounds or when variability in exposure results is significant  Where to sample? – Areas/activities/operations with potential for exposures defined during Industrial Hygiene Risk Assessment  When should the sampling be done? – Representative sampling in all shifts – Different operators, different shifts ©International Safety Systems, Inc. www.issehs.com
  33. 33. Challenges in API Exposure Monitoring  OELs are not available for large number of APIs and intermediates  Validated methods are not available for large number of API analysis  Potent compounds require meticulous handling of samples to avoid cross contamination  Limited accredited laboratories are available in USA for APIs – Each API employee and swab sampling method validation include sensitivity (LOQ lower than high API), desorption efficiency, number of spike samples and other critical parameters ©International Safety Systems, Inc. www.issehs.com
  34. 34. Addressing Challenges API Exposure Monitoring  Use validated methods and accredited lab with API analysis experience especially for highly potent APIs as employee health depends on the results  Follow rigorous validated sampling methods to avoid sample contamination (disposal powder free gloves, plastic Ziplock bag for every sample)  Use surrogate monitoring if API validated methods are not available ©International Safety Systems, Inc. www.issehs.com Implement Established Exposure Controls following Control Banding Approach
  35. 35. Surrogate Monitoring Good Practices Guidelines - ISPE  International Society for Pharmaceutical Engineering (ISPE)  Standardized Measurement of Equipment Particulate Airborne Concentration (SMEPAC) Committee  ISPE Good Practice Guide: Assessing the Particulate Containment Performance of Pharmaceutical Equipment  Standardized method of measuring – Performance of containment systems against specific challenge – Establish an agreed and valid method that can be used to meet the requirements of practitioners and supplier organizations
  36. 36. Example of Laminar Flow Booth Surrogate Monitoring at LFB
  37. 37. API/Chemical Plants: Exposure Controls: Reactor Charging  Potential for exposure during: – Manual charging of solids – Handling of empty bags/super-sacks – (major source of exposure) Very effective: Charging booth Effective: Reactor Charging with LEV Empty bags collected in plastic bag from inside of glove box
  38. 38. API/Chemical Plants: Exposure Controls: Tanker Unloading Nitrogen – pushing residual chemical Secured connections with arrangement to rinse piping before disconnecting
  39. 39. API/Chemical Plants: Exposure Controls: Tanker Unloading Barrel Transfer of Chemicals Potential for exposure during transfer with left in hose A barrel decanting unit reduces leaks, spills and exposures Never to use air pressure
  40. 40. Dispensing and Weighing of Solids - Small Volume Not Effective: LFB are nt effective in reducing exposure below about 50 ug/m3 Dispense cell, isolator for high potent compounds
  41. 41. Solid Discharging Fully Contained Discharge Through Weigh Isolator
  42. 42. Ventilated Balance Safety Enclosure (VBSE)® – For High Potent Compounds in laboratory  Face velocity – Not too high – Not too low – 50 fpm to 70 fpm  HEPA filtration  Ducted  Size of opening for weighing - adjustable  Air flow monitor and alarm  Can be customized ©International Safety Systems, Inc. www.issehs.com
  43. 43. Efficient LEV design
  44. 44. Principles of General Ventilation System  Maintain always negative air pressure in the contamination generating room with respect to rest of the building  Replace exhaust air by make-up air  Do not install an exhaust fan near an intake opening or window (e.g., contaminated air will be pulled back into building rather than exhausted)  Ensure contaminated air does not pass through breathing zone
  45. 45. Efficient Local Exhaust Ventilation (LEV)  Inefficient ventilation system design is one of the most common walkthrough findings  The designing contractors are often not knowledgeable of design principles  Adequate capture efficiency has not been accomplished despite money spent in energy consumption  Knowing basic principles of ventilation system helps in (a) modifying existing ventilation systems and (b) in guiding designing contractors towards efficient ventilation system design In an efficient LEV, energy consumption is minimum and contaminant removal from operator’s breathing zone is maximum
  46. 46. Hood Provide a flange or hood at the air inlet. 25% more energy is required to capture contaminates from the front, when a flange or hood is not provided Locate hood closed to contaminant generation Air is drawn from back side also Air drawn from front only PreferredReduce distance if feasible
  47. 47. Hood Tapered hood are more efficient than right angle hoods Locate hood so that contaminants do not pass through the breathing zone of an operator Enclose sides as much as feasible
  48. 48. Duct Straight duct is more efficient than a duct with many bends and elbows. Smaller duct length and smoother duct surface improves efficiency Abrupt change in duct diameter and branch entry reduce the efficiency For most of LEVs, round duct is preferred over rectangular duct –Prevents accumulation of solids –Makes less noise –Durable Examples of inefficient ducts
  49. 49. Application of LEV Solid charging Empty bags are placed in this large bag Solid filling in drums Barrel decanting Glove box for highly toxic compounds Portable extractor
  50. 50. Ventilation measurements  Velocity measurement on the face of the hood is best indicator of efficiency  Depending on the face area, measure air velocity at several points on the face and determine average face velocity  The face velocity to capture most of the contaminants is 100 f/min (0.5 m/sec) Instruments used to measure face and duct velocities
  51. 51. Range of Capture Velocities Condition of Dispersion Examples Capture Velocity (f/min) Capture Velocity (m/sec) Released with practically no velocity into quiet air Evaporation from tanks; degreasing, etc. 100 0.5 Released at low velocity into moderately still air Spray booths; intermittent container filling; low speed conveyer transfers; welding; plating; pickling 100-200 0.5-1 Active generation into zone of rapid air motion Spray painting in shallow booths; barrel filling; conveyer loading; crushers 200-500 1-2.5
  52. 52. Range of Duct Velocities Material Example Duct Velocity (f/min) Duct velocity (m/sec) Vapors, gases All vapors and gases 1000-1500 5-7.5 Spray painting Paint aerosols 1000-3000 5-15 Fumes Lead, welding 1500-2000 7.5-10 Dry dusts Fine rubber dust 2500-3500 12.5-17.5 General industrial dust Clay dust, silica flour 3500-4000 17.5-20 Heavy dusts Sand blast dust 4000-4500 20-22.5 Heavy or moist dust Moist cement dusts 4500 + 22.5+
  53. 53. Measuring Ventilation System Performance Manometer/Magneh elic gauge that continuously measures pressure drop across filter. Assists in determining when to change filter
  54. 54. HVAC System and Dust Collectors  Directional flow in Room: Clean air flows top-down and contaminated air flows bottom-side, away from operator breathing zone  Recirculation through HEPA filter is permitted for OEB1-2  Recirculated air from OEB 3 and 4 API Rooms through dual HEPA  OEB 4 compounds, “Sink” airlock to provide negative pressure gradients from both process area and common corridor  Bag-In/Bag-Out safe change system at exhaust grills to minimize duct contamination
  55. 55. Zoning for High Potent Compound Handling  Red – Potentially contaminated area – Not used for gowning  Yellow – Less or no contamination – De-gowning area  Green Zoning – Clean non-contaminated area – Paper work is done – Gowning is done ©International Safety Systems, Inc. www.issehs.com
  56. 56. Importance of Swab Sampling to determine degree of surface contamination  Determines degree of surface contamination  Useful in determining if Green Zone is contaminated or not  Contact Surfaces (door handles)  Acceptable Surface Limits  Lessons learned – Do no assume ethanol is good decontaminating agents for all APIs – Do not assume cleaning method has decontaminated areas©International Safety Systems, Inc. www.issehs.com
  57. 57. Gowning –Degowning for High Potent Compounds  Two pairs of disposable – Gloves – Gowns – Shoe Cover  Disposal of outer pair after work is done in Red Zone just before entering Yellow Zone ©International Safety Systems, Inc. www.issehs.com
  58. 58. Challenges in Respiratory Protection  Variable Assigned Protection Factor for Powered Air Purifying Respirators – 50 to 1000  Disposable Vs. Reusable hood – Disposable preferred – cost is high – Reusable – API contamination of PAPR hood identified  Cleaning validation ©International Safety Systems, Inc. www.issehs.com
  59. 59. Challenges  Limited Resources – IH professionals  QA in exposure assessment data  Financial constrains – Price Controls – Competition  Manufacturing and outsourcing is increasing rapidly and corporate EHS and other resources are decreasing  Trained corporate EHS professionals are unable to cop-up with demand for assistance  Distance, time difference  Limited sensitivity of site professionals to potent compounds 59
  60. 60. Approaches: Corporate and Regional EHS  Commendable efforts  Audits  Regional training programs and meetings  Strong contract manufacturing programs  Emphasis on selection of credible, competent and cost-effective EHS service providers  Providing limited financial support 60
  61. 61. Approaches  Education Programs in Industrial Hygiene – University Level – Pharma specific training modules  Managing cost effectively – Cost effective consulting – Exposure assessment strategy – three samples /HEG/API , never 1 sample – Analytical cost discounts – Return on investment (e.g., savings from loss of API) – Not loosing focus on QA 61
  62. 62. Approaches  Empowering region and manufacturing sites in EHS  Training – At the foundation of sustainable EHS program – Site specific, anecdotal , workshop at the site – One corporation spends closed to $1B in all training  Qualitative Risk assessment and Control Banding – If exposure is obvious, why do monitoring? – Exposure control and then monitoring  Sanofi approach of Industrial Hygiene Education Academy 62
  63. 63. Approaches – Supply Chain  Corporate requirement for supplier to demonstrate exposure is below OEL through surrogate monitoring  Corporate and third party due diligence audits  Local services provider to do hand-holding for some time – On site training on process safety and IH – Limited exposure assessment – Periodic supervision – 7/24 support  Limit number of suppliers based on EHS performance  Shutting down operation when risk is imminent- provide limited assistance in reducing risk 63
  64. 64. Conclusions  Potential process safety and chemical exposure risks are high in pharmaceutical and chemical industries. The risks are manageable – Understanding and communicating – Empowering line managers – Capitalizing on available resources – Implementing feasible risk control measures  Potential risk is even higher at supply manufacturing sites. The risk is manageable – Effective auditing – Limited hand-holding ©International Safety Systems, Inc. www.issehs.com

    Soyez le premier à commenter

    Identifiez-vous pour voir les commentaires

  • HarshadKalavadia

    Jan. 19, 2015
  • samsonponselvan

    Feb. 27, 2017
  • ParastooAlikhani

    Jan. 23, 2019
  • FukangChang

    Feb. 19, 2019
  • SotiriosTragoulias

    Nov. 25, 2019
  • christantokalalinggi

    Dec. 10, 2019

Exposure Risk Assessment Challenges : Occupational Hygiene in the Pharmaceutical and Chemical Industries, AIHA 2013, Asia Pacific OH Conference, Singapore

Vues

Nombre de vues

3 981

Sur Slideshare

0

À partir des intégrations

0

Nombre d'intégrations

1 663

Actions

Téléchargements

0

Partages

0

Commentaires

0

Mentions J'aime

6

×